Page last updated: 2024-08-16

rivastigmine and 2,8-dimethyl-3-methylene-1-oxa-8-azaspiro(4,5)decane

rivastigmine has been researched along with 2,8-dimethyl-3-methylene-1-oxa-8-azaspiro(4,5)decane in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Honma, A	1

Reviews

1 review(s) available for rivastigmine and 2,8-dimethyl-3-methylene-1-oxa-8-azaspiro(4,5)decane

Article	Year
[Therapeutic agents for Alzheimer's disease]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1998, Jan-10, Volume: 87, Issue:1 Topics: Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Clinical Trials as Topic; Donepezil; Humans; Indans; Monoamine Oxidase Inhibitors; Neuropeptides; Phenylcarbamates; Piperidines; Receptor, Muscarinic M1; Receptors, Muscarinic; Rivastigmine; Spiro Compounds; Tacrine	1998

Article

Year

[Therapeutic agents for Alzheimer's disease].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1998, Jan-10, Volume: 87, Issue:1

Topics: Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Clinical Trials as Topic; Donepezil; Humans; Indans; Monoamine Oxidase Inhibitors; Neuropeptides; Phenylcarbamates; Piperidines; Receptor, Muscarinic M1; Receptors, Muscarinic; Rivastigmine; Spiro Compounds; Tacrine

1998